Globalbio magazine volume 112

撰文GlobalBio & Investment
日期2024-01-25
Globalbio magazine volume 112
In volume 112, Globalbio magazine dives into the nuts and bolts of implementing innovative medical tech.
 
Breaking through the barriers from research to clinical trials is just the start, but the real challenge kicks in after validation.
 
Taiwan's healthcare system is renowned globally, yet innovative medical solutions seem distant to the public. Companies dive into R&D but struggle to bring innovations to hospitals, leaving both sides frustrated!
 
2024 brings forth a wave of reforms in healthcare policies. The recent buzz about blending commercial insurance with innovative medical products sparks hope. Is there a solution for innovation to thrive within our healthcare systems?
 
Let's unravel the path to making innovation in healthcare a reality!
Read more: https://bit.ly/buyv112
 
Follow #Globalbio for more eye-opening news! #Healthcare #MedicalTech #InnovativeSolutions #MedicalInsurance